Table 1 The demographic and clinical characteristics of the study participants
From: Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease
Parameters | Kawasaki disease | Controls (n = 20) | |
|---|---|---|---|
Acute phase (n = 24) | Remission phase (n = 19) | ||
Age, year | 2.75 (0.6–5) | NA | 2.38 (0.9–4.5) |
Sex, Female/Male | 11/14 | NA | 8/12 |
CRP, mg/L | 76.25 (20–151)#, ∗ | 2.76 (0.8–5.28) | 2.35 (0.7–3.28) |
ESR, mm/h | 51.37 (11–98)# | 53.67 (9–76)# | 7 (3–11) |
IgG, g/L | 6.295 (1.82–16.1)# | NA | 10.22 (6.08–14.37) |
IgA, g/L | 1.715 (0.91–2.92) | NA | 1.91 (0.71–3.1) |
IgM, g/L | 0.99 (0.19–1.77) | NA | 1.035 (0.69–1.93) |
WBC, 109/L | 14.31 (5.89–35)#, ∗ | 8.729 (4.82–13.79) | 7.735 (5.31–10.03) |
Neutrophils, 109/L | 10.14 (2.52–33.69)#, ∗ | 2.98 (1.98–5.09) | 2.58 (2.06–4.69) |
Lymphocytes, 109/L | 2.915 (0.88–8.82) | 3.736 (1.92–6.75) | 4.085 (1.01–5.28) |